Boughey, Judy C. https://orcid.org/0000-0003-3820-3228
Dietz, Jill R.
Willey, Shawna C.
Boolbol, Susan K.
Kuehn, Thorsten
Article History
Received: 8 April 2025
Accepted: 1 July 2025
First Online: 28 July 2025
Disclosure
: The impetus for this editorial comes from the Inaugural Transatlantic Breast Cancer Collaborative (TBCC). All authors attended and received funding and honoraria from EndoMag to participate. Dr Judy Boughey receives funding paid to her institution from Eli Lilly and SymBioSis and QuantumLeap HealthCare and sits on the Data Safety Monitoring Committee of CairnSurgical. She has received honoraria from PER, PeerView, OncLive, and UpToDate and honoraria and travel expenses from EndoMag. Dr. Shawna Willey is on the Speaker’s Bureau for Medtronic, EndoMag, and Pacira and has received honoraria and travel expenses. She is a paid consultant for Hologic. Prof. Thorsten Kuehn has received honoraria from Merit Medical, Sirius Medical, EndoMag, MSD, Lilly, Exact Sciences, and Novartis. Dr. Susan K. Boolbol is co-founder of Peace Medical Consulting LLC and has received honoraria and travel expenses from EndoMag. She is a consultant for Hologic. Dr. Jill Dietz is co-founder of Peace Medical Consulting LLC and Chief Medical Director of Cyduct Diagnostics and has received honorarium and travel expenses from Lumicell and EndoMag.
Free to read: This content has been made available to all.